Performing gynecologic cancer surgery during the COVID-19 pandemic in Turkey: A multicenter retrospective observational study.

Autor: Dursun P; Private Gynecologic Oncology, Ankara, Turkey., Dervisoglu H; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Dr. Abdurrahman Yurtaslan Ankara Oncological Education and Research Hospital, Ankara, Turkey., Daggez M; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Erciyes University Faculty of Medicine, Kayseri, Turkey., Turan T; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Ankara City Hospital, Ankara, Turkey., Kiliç F; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Ankara City Hospital, Ankara, Turkey., Tekin ÖM; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Ankara City Hospital, Ankara, Turkey., Üreyen I; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, University of Health Sciences Antalya Education and Research Hospital, Antalya, Turkey., Toptaş T; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, University of Health Sciences Antalya Education and Research Hospital, Antalya, Turkey., Demirayak G; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Bakirkoy Dr. Sadi Konuk Training & Research Hospital, Istanbul, Turkey., Önder AB; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Bakirkoy Dr. Sadi Konuk Training & Research Hospital, Istanbul, Turkey., Çelik Ç; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Selcuk University Faculty of Medicine, Konya, Turkey., Bayramoğlu D; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Selcuk University Faculty of Medicine, Konya, Turkey., Guzel AB; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Cukurova University Faculty of Medicine, Adana, Turkey., Arioz DT; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Afyonkarahisar Health Sciences University Medical School, Afyonkarahisar, Turkey., Bilir F; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Afyonkarahisar Health Sciences University Medical School, Afyonkarahisar, Turkey., Ozdemir IA; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Medipol University, Istanbul, Turkey., Tasci T; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Bahçeşehir University Medical Park Goztepe Hospital, Istanbul, Turkey., Karalok A; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Liv Hospital Ulus, Istanbul, Turkey., Karateke A; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Medeniyet University, Istanbul, Turkey.
Jazyk: angličtina
Zdroj: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2020 Oct; Vol. 151 (1), pp. 33-38. Date of Electronic Publication: 2020 Aug 11.
DOI: 10.1002/ijgo.13296
Abstrakt: Objective: To report the perioperative outcomes of 200 patients with gynecologic cancer who underwent surgery during the Novel Coronavirus Disease (COVID-19) pandemic and the safety of surgical approach.
Methods: Data of patients operated between March 10 and May 20, 2020, were collected retrospectively. Data were statistically analyzed using IBM Statistical Package for the Social Sciences (SPSS) Statistics for Windows v. SP21.0.
Results: Data of 200 patients were included. Their mean age was 56 years. Of the patients, 54% (n=108), 27.5% (n=55), 12.5% (n=25), and 2% (n=4) were diagnosed as having endometrial, ovarian, cervical, and vulvar cancer, respectively. Of them, 98% underwent non-emergent surgery. A minimally invasive surgical approach was used in 18%. Stage 1 cancer was found in 68% of patients. Surgeons reported COVID-related changes in 10% of the cases. The rate of postoperative complications was 12%. Only two patients had cough and suspected pneumonic lesions on thoracic computed tomography postoperatively, but neither was positive for COVID-19 on polymerase chain reaction testing.
Conclusion: Based on the present findings, it is thought that gynecologic cancer surgery should continue during the COVID-19 pandemic while adhering to the measures. Postponement or non-surgical management should only be considered in patients with documented infection. Gynecologic cancer surgery should continue during the COVID-19 pandemic while adhering to measures. Only 1% of patients developed COVID-19-related symptoms during the postoperative follow-up period.
(© 2020 International Federation of Gynecology and Obstetrics.)
Databáze: MEDLINE
Externí odkaz: